Clinical Trials Browser

Phase 2/3 × Recruiting × Pancreatic Adenocarcinoma × Clear all

NCT05268692 2022-03-07

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma